BANKA NSE filing

Banka BioLoo Appoints Srilakshmi Chunduru as Company Secretary & Compliance Officer

The RealCase readLow impact Neutral

Banka BioLoo Limited has appointed Ms. Srilakshmi Manjula Chaitanya Chunduru as the new Company Secretary and Compliance Officer, effective May 26, 2026. She is authorized, along with the CEO and CFO, to determine the materiality of events and make disclosures to stock exchanges as per SEBI regulations.

Why it matters

This is a routine regulatory compliance update regarding changes in personnel authorized for disclosures. It does not directly impact the company's business operations, financial performance, or strategic direction.

The market read

The announcement pertains to a change in Key Managerial Personnel for regulatory compliance and disclosure purposes. It does not contain any financial performance data or strategic business updates that would indicate a positive or negative sentiment.

Banka BioLoo Limited has announced a change in the authorization of Key Managerial Personnel (KMPs) for determining the materiality of events or information and for making disclosures to the Stock Exchange under Regulation 30 of SEBI (LODR) Regulations, 2015. This change is consequent to the appointment of a new Company Secretary and Compliance Officer.

With effect from 26 May 2026, the Board of Directors has severally authorized Mr. Vishal Murarka, Chief Executive Officer and Executive Director, and Mr. Lakkimsetty Venkata Naga Padmanabham, Chief Financial Officer, for these responsibilities. Their contact details for the corporate office in Hyderabad have been provided.

Furthermore, Ms. Srilakshmi Manjula Chaitanya Chunduru has been appointed as the new Company Secretary and Compliance Officer and is also severally authorized for making disclosures to the Stock Exchanges. Her contact details are also provided.

Filing to action

What to do with a filing like this

Banka BioLoo Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Banka BioLoo Limited. Read the original for the full detail.

View original filing